Predictive spatial risk model of poliovirus to aid prioritization and hasten eradication in Nigeria

BMC Medicine

Volumn 12, Issue 1, 2014, Pages

  Upfill Brown, Alexander M ^a   Lyons, Hil M ^a   Pate, Muhammad A ^b   Shuaib, Faisal ^c,d,e   Baig, Shahzad ^d,f   Hu, Hao ^a   Eckhoff, Philip A ^a   Chabot Couture, Guillaume ^a  

^a INSTITUTE FOR DISEASE MODELING   (United States)

^b DUKE UNIVERSITY   (United States)

^c National Polio Emergency Operations Center   (Nigeria)

^d NATIONAL PRIMARY HEALTH CARE DEVELOPMENT AGENCY   (Nigeria)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f Kano Polio Emergency Operations Center   (Nigeria)

Author keywords

Disease mapping; Polio eradication; Risk modeling; Spatial epidemiology

Indexed keywords

ACCURACY; AGE DISTRIBUTION; ARTICLE; BAYESIAN LEARNING; DISEASE SURVEILLANCE; FLACCID PARALYSIS; MEDICAL INFORMATION; NIGERIA; POLIOMYELITIS VIRUS; POLIOMYELITIS VIRUS 1; POLIOVIRUS TYPE 3; POLITICS; PREDICTION; PROBABILITY; RELIGION; RISK ASSESSMENT; STATISTICAL MODEL; UNCERTAINTY; VACCINATION; VIRAL CLEARANCE; VIRUS TRANSMISSION; BAYES THEOREM; DISEASE ERADICATION; FEMALE; HEALTH CARE PLANNING; HUMAN; IMMUNOLOGY; MEDICAL GEOGRAPHY; ORGANIZATION AND MANAGEMENT; POISSON DISTRIBUTION; POLIOMYELITIS; RISK; STATISTICS AND NUMERICAL DATA; TIME; TRANSMISSION; VIROLOGY;

BAYES THEOREM; DISEASE ERADICATION; FEMALE; GEOGRAPHY, MEDICAL; HEALTH RESOURCES; HUMANS; MODELS, STATISTICAL; NIGERIA; POISSON DISTRIBUTION; POLIOMYELITIS; POLIOVIRUS; RISK; TIME FACTORS; UNCERTAINTY;

EID: 84903141726     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-12-92     Document Type: Article

References (60)

1. Aylward B, Yamada T. The Polio endgame. N Engl J Med 2011, 364:2273-2275. 10.1056/NEJMp1104329, 21675884.
2. World Health Organization Polio eradication & endgame strategic plan 2013-2018. [Online]. Available from: http://www.polioeradication.org, Geneva, World Health Organization.
3. World Health Assembly Poliomyelitis: Intensification of the Global Eradication Initiative 2012, Geneva: World Health Organization, World Health Assembly.
4. National Primary Health Care Development Agency 2012 Nigeria polio eradication emergency plan. 2012, [Online]. Available from: http://www.polioeradication.org, Abuja, National Primary Health Care Development Agency.
5. Grassly NC. The final stages of the global eradication of poliomyelitis. Philos Trans R Soc London Ser B 2013, 368:20120140. doi:10.1098/rstb.2012.0140.
6. Lowther SA, Roesel S, O'Connor P, Landaverde M, Oblapenko G, Deshevoi S, Ajay G, Buff A, Safwat H, Salla M, Tangermann R, Khetsuriani N, Martin R, Wassilak S. World health organization regional assessments of the risks of poliovirus outbreaks. Risk Anal 2013, 33:664-679. doi:10.1111/risa.12032, 10.1111/risa.12032, 23520991.
7. O'Reilly KM, Chauvin C, Aylward RB, Maher C, Okiror S, Wolff C, Nshmirimana D, Donnelly CA, Grassly NC. A statistical model of the international spread of wild poliovirus in Africa used to predict and prevent outbreaks. PLoS Med 2011, 8, doi:10.1371/journal.pmed.1001109.
8. Best N, Richardson S, Thomson A. A comparison of Bayesian spatial models for disease mapping. Stat Methods Med Res 2005, 14:35-59. doi:10.1191/0962280205sm388oa, 10.1191/0962280205sm388oa, 15690999.
9. Brooker S, Clements ACA, Hotez PJ, Hay SI, Tatem AJ, Bundy DAP, Snow RW. The co-distribution of Plasmodium falciparum and hookworm among African schoolchildren. Malar J 2006, 5:99. doi:10.1186/1475-2875-5-99, 10.1186/1475-2875-5-99, 1635726, 17083720.
10. Hay SI, Guerra CA, Gething PW, Patil AP, Tatem AJ, Noor AM, Kabaria CW, Manh BH, Elyazar IRF, Brooker S, Smith DL, Moyeed RA, Snow RW. A world malaria map: Plasmodium falciparum endemicity in 2007. PLoS Med 2009, 6:1000048. doi:10.1371/journal.pmed.1000048.
11. Clements ACA, Garba A, Sacko M, Touré S, Dembelé R, Landouré A, Bosque-Oliva E, Gabrielli AF, Fenwick A. Mapping the probability of schistosomiasis and associated uncertainty, West Africa. Emerg Infect Dis 2008, 14:1629-1632. doi:10.3201/eid1410.080366, 10.3201/eid1410.080366, 2609896, 18826832.
12. Clements ACA, Lwambo NJS, Blair L, Nyandindi U, Kaatano G, Kinung'hi S, Webster JP, Fenwick A, Brooker S. Bayesian spatial analysis and disease mapping: tools to enhance planning and implementation of a schistosomiasis control programme in Tanzania. Trop Med Int Heal 2006, 11:490-503. doi:10.1111/j.1365-3156.2006.01594.x.
13. Clements ACA, Brooker S, Nyandindi U, Fenwick A, Blair L. Bayesian spatial analysis of a national urinary schistosomiasis questionnaire to assist geographic targeting of schistosomiasis control in Tanzania, East Africa. Int J Parasitol 2008, 38:401-415. doi:10.1016/j.ijpara.2007.08.001, 10.1016/j.ijpara.2007.08.001, 2653941,2653941, 17920605.
14. Vounatsou P, Raso G, Tanner M, N'goran EK, Utzinger J. Bayesian geostatistical modelling for mapping schistosomiasis transmission. Parasitology 2009, 136:1695-1705. doi:10.1017/S003118200900599X, 10.1017/S003118200900599X, 19490724.
15. Wang X-H, Zhou X-N, Vounatsou P, Chen Z, Utzinger J, Yang K, Steinmann P, Wu X-H. Bayesian spatio-temporal modeling of Schistosoma japonicum prevalence data in the absence of a diagnostic 'gold' standard. PLoS Negl Trop Dis 2008, 2:250. doi:10.1371/journal.pntd.0000250.
16. Pullan RL, Gething PW, Smith JL, Mwandawiro CS, Sturrock HJW, Gitonga CW, Hay SI, Brooker S. Spatial modelling of soil-transmitted helminth infections in Kenya: a disease control planning tool. PLoS Negl Trop Dis 2011, 5:958. doi:10.1371/journal.pntd.0000958.
17. Raso G, Vounatsou P, Gosoniu L, Tanner M, N'Goran EK, Utzinger J. Risk factors and spatial patterns of hookworm infection among schoolchildren in a rural area of western Côte d'Ivoire. Int J Parasitol 2006, 36:201-210. doi:10.1016/j.ijpara.2005.09.003, 10.1016/j.ijpara.2005.09.003, 16259987.
18. Raso G, Vounatsou P, Singer BH, N'Goran EK, Tanner M, Utzinger J. An integrated approach for risk profiling and spatial prediction of Schistosoma mansoni-hookworm coinfection. Proc Natl Acad Sci 2006, 103:6934-6939. doi:10.1073/pnas.0601559103, 10.1073/pnas.0601559103, 1458997, 16632601.
19. Diggle P, Thompson M, Christensen O, Rowlingson B, Obsomer V, Gardon J, Wanji S, Takougang I, Enyoun P, Kamgno J, Remme J, Boussinesq M, Molyneux D. Spatial modelling and the prediction of Loa loa risk: descision making under uncertainty. Ann Trop Med Parasitol 2007, 101:499-509. doi:10.1179/136485907X229121, 10.1179/136485913X13789813917463, 17716433.
20. Paul M, Held L. Predictive assessment of a non-linear random effects model for multivariate time series of infectious disease counts. Stat Med 2011, 30:1118-1136. doi:10.1002/sim.4177.
21. Stanton MC, Agier L, Taylor BM, Diggle PJ. Towards realtime spatiotemporal prediction of district level menigitis incidence in sub-Saharan Africa. J R Stat Soc A 2013, [Online]. doi:10.1111/rssa.12033.
22. Musal M, Aktekin T. Bayesian spatial modeling of HIV mortality via zero-inflated poisson models. Stat Med 2013, 32:267-281. doi:10.1002/sim.5457, 10.1002/sim.5457, 22807006.
23. Agarwal DK, Gelfand AE, Citron-Pousty S. Zero-inflated models with application to spatial count data. Environ Ecol Stat 2002, 9:341-355.
24. Min Y, Agresti A. Random effect models for repeated measures of zero-inflated count data. Stat Model 2005, 5:1-19. doi:10.1191/1471082X05st084oa.
25. Neelon BH, O'Malley AJ, Normand S-LT. A Bayesian model for repeated measures zero-inflated count data with application to outpatient psychiatric service use. Stat Modelling 2010, 10:421-439. doi:10.1177/1471082X0901000404, 10.1177/1471082X0901000404, 3039917, 21339863.
26. Neelon B, Ghosh P, Loebs PF. A spatial Poisson hurdle model for exploring geographic variation in emergency department visits. J R Stat Soc Ser A 2013, 176:389-413. doi:10.1111/j.1467-985X.2012.01039.x.
27. Marx A, Glass JD, Sutter RW. Differential diagnosis of acute flaccid paralysis and its role in poliomyelitis surveillance. Epidemiol Rev 2000, 22:298-316. 10.1093/oxfordjournals.epirev.a018041, 11218380.
28. Jenkins HE, Aylward RB, Gasasira A, Donnelly CA, Mwanza M, Corander J, Garnier S, Chauvin C, Abanida E, Pate MA, Adu F, Baba M, Grassly NC. Implications of a circulating vaccine-derived poliovirus in Nigeria. N Engl J Med 2010, 362:2360-2369. doi:10.1056/NEJMoa0910074, 10.1056/NEJMoa0910074, 20573924.
29. Jenkins HE, Aylward RB, Gasasira A, Donnelly CA, Abanida EA, Koleosho-Adelekan T, Grassly NC. Effectiveness of immunization against paralytic poliomyelitis in Nigeria. N Engl J Med 2008, 359:1666-1674. doi:10.1056/NEJMoa0803259, 10.1056/NEJMoa0803259, 18923171.
30. O'Reilly KM, Durry E, ul Islam O, Quddus A, Abid N, Mir TP, Tangermann RH, Aylward RB, Grassly NC. The effect of mass immunisation campaigns and new oral poliovirus vaccines on the incidence of poliomyelitis in Pakistan and Afghanistan, 2001-11: a retrospective analysis. Lancet 2012, 380:491-498. doi:10.1016/S0140-6736(12)60648-5, 10.1016/S0140-6736(12)60648-5, 3418593, 22766207.
31. National Population Commission of Nigeria Report of Nigeria's national population commission on the 2006 census. Popul Dev Rev 2007, 33:206-210. National Population Commission of Nigeria.
32. GADM GADM Database of Global Administrative Areas, Version 2.0. [Online]. Available from: http://www.gadm.org [Accessed 10th Apr 2013], GADM.
33. Mangal TD, Aylward RB, Mwanza M, Gasasira A, Abanida E, Pate MA, Grassly NC. Key issues in the persistence of poliomyelitis in Nigeria: a case-control study. Lancet Glob Health 2014, 2:90-97.
34. Behrend M, Hu H, Nigmatulina KR, Eckhoff P. A quantitative suvery of the literature on poliovirus infection and immunity. Int J Infect Dis 2014, 18:4-13.
35. Mullahy J. Specification and testing of some modified count data models. J Econom 1986, 33:341-365. doi:10.1016/0304-4076(86)90002-3.
36. Pohllmeier W, Ulrich V. An econometric model of the two-part decisionmaking process in the demand for health care. J Hum Resour 1995, 30:339-361.
37. Besag J, York J, Mollié A. Bayesian image restoration, with two applications in spatial statistics. Ann Inst Statist Math 1991, 43:1-59.
38. Besag J, Kooperberg C. On conditional and intrinsic autoregressions. Biometrika 1995, 82:733-746. doi:10.1093/biomet/82.4.733.
39. Lunn DJ, Thomas A, Best N, Spiegelhalter D. WinBUGS - A Bayesian modelling framework: concepts, structure, and extensibility. Stat Comput 2000, 10:325-337.
40. Sturtz S, Ligges U, Gelman A. R2WinBUGS: a package for running WinBUGS from R. J Stat Softw 2005, 12:1-16.
41. Plummer M, Best N, Cowles K, Vines K. CODA: convergence diagnosis and output analysis for MCMC. R News 2006, 6:7-11.
42. R Core Team R: A Language and Evironment for Statistical Computing 2013, Vienna: R Foundation for Statistical Computing, R Core Team.
43. Gelman A, Rubin DB. lnference from iterative simulation using multiple sequences. Stat Sci 1992, 7:457-472.
44. Brooks SP, Roberts GO. Assessing convergence of Markov chain Monte Carlo algorithms. Stat Comput 1998, 8:319-335.
45. Spiegelhalter DJ, Best NG, Carlin BP, van der Linde A. Bayesian measures of model complexity and fit. J R Stat Soc Ser B 2002, 64:583-639. doi:10.1111/1467-9868.00353.
46. Fielding AH, Bell JF. A review of methods for the assessment of prediction errors in conservation presence/absence models. Environ Conserv 1997, 24:38-49. doi:10.1017/S0376892997000088.
47. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J-C, Müller M. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 2011, 12:77. 10.1186/1471-2105-12-77, 3068975, 21414208.
48. Brooker S, Hay SI, Bundy DAP. Tools from ecology: useful for evaluating infection risk models?. Trends Parasitol 2002, 18:70-74. 10.1016/S1471-4922(01)02223-1, 3166848, 11832297.
49. Greiner M, Pfeiffer D, Smith RD. Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Prev Vet Med 2000, 45:23-41. 10.1016/S0167-5877(00)00115-X, 10802332.
50. Thompson KM, Pallansch MA, Tebbens RJD, Wassilak SG, Cochi SL. Modeling population immunity to support efforts to end the transmission of live polioviruses. Risk Anal 2013, 33:647-663. doi:10.1111/j.1539-6924.2012.01891.x, 10.1111/j.1539-6924.2012.01891.x, 22985171.
51. Hu H, Nigmatulina K, Eckhoff P. The scaling of contact rates with population densitity for the infectious disease models. Math Biosci 2013, 244:125-134. 10.1016/j.mbs.2013.04.013, 23665296.
52. Grassly NC, Fraser C, Wenger J, Deshpande JM, Sutter RW, Heymann DL, Aylward RB. New strategies for the elimination of polio from India. Science 2006, 314:1150-1153. doi:10.1126/science.1130388, 10.1126/science.1130388, 17110580.
53. Webster P. A polio-free world?. Lancet 2005, 366:359-360. 10.1016/S0140-6736(05)67008-0, 16060049.
54. Orenstein WA, Bernier RH, Hinman AR. Assessing vaccine efficacy in the field. Epidemiol Rev 1988, 10:212-241.
55. Triki H, Ould Mohamed Abdallah MV, Ben Aissa R, Bouratbine A, Ben Ali Kacem M, Bouraoui S, Koubaa C, Zouari S, Mohsni E, Crainic R, Dellagi K. Influence of host related factors on the antibody response to trivalent oral polio vaccine in Tunisian infants. Vaccine 1997, 15:1123-1129. 10.1016/S0264-410X(97)00001-7, 9269056.
56. Patriarca PA, Wright PF, John TJ. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev Infect Dis 1991, 13:926-939. 10.1093/clinids/13.5.926, 1660184.
57. Callaway E. Polio's moving target. Nature 2013, 496:290-292. 10.1038/496290a, 23598322.
58. National Population Commission [Nigeria] Nigeria Demographic and Health Survey 2008 2009, Abuja, Nigeria: Technical report, National Population Commission and ICF Macro, National Population Commission [Nigeria].
59. Grassly NC, Jafari H, Bahl S, Sethi R, Deshpande JM, Wolff C, Sutter RW, Aylward RB. Waning intestinal immunity after vaccination with oral poliovirus vaccines in India. J Infect Dis 2012, 205:1554-1561. doi:10.1093/infdis/jis241, 10.1093/infdis/jis241, 22448007.
60. Mayer BT, Eisenberg JNS, Henry CJ, Gomes MGM, Ionides EL, Koopman JS. Successes and shortcomings of polio eradication: a transmission modeling analysis. Am J Epidemiol 2013, 177:1236-1245. doi:10.1093/aje/kws378, 10.1093/aje/kws378, 3664334, 23592542.